June Agenda

Class Is in Session! Diagnosing and Managing ADHD in Children and Young Adults

All Sessions Will Be Held in Eastern Time (ET)

This two-part CE program will examine attention-deficit/hyperactivity disorder (ADHD) across key developmental stages, from early childhood through emerging adulthood. The first session will focus on building evidence-based foundations in pediatric ADHD, including accurate diagnosis, stimulant and non-stimulant treatment strategies, myth-busting around safety concerns, and collaborative, individualized care planning. The second session will address the transition to college and early adulthood, highlighting evolving clinical needs, executive-function support, safe prescribing practices, prevention of misuse or diversion, and strategies to ensure continuity of care during this critical period.

Saturday, June 27, 2026

Add to Cart

9:00 am - 10:00 am ET

The Early Years of ADHD: Building Evidence-Based Foundations

Jeffrey R. Strawn, MD

This session will provide a developmentally informed, evidence-based approach to diagnosing and managing ADHD in children and adolescents. Clinicians will review stimulant and non-stimulant treatment options, address common safety concerns and misconceptions, and explore strategies for personalizing care based on comorbidities, symptom profiles, and family preferences. The program will emphasize practical, collaborative approaches that support long-term developmental outcomes across home, school, and clinical settings.

10:00 am - 11:00 am ET

Industry Session^†: Expanding Our View of ADHD

Ann Childress, MD

Sponsored by Supernus

11:00 am - 11:05 am ET

Break

11:05 am - 12:05 pm ET

ADHD University: Managing Attention Deficit-Hyperactivity Disorder in College-Aged Individuals

Andrew J. Cutler, MD

This session will focus on the evolving clinical and functional needs of adolescents with ADHD transitioning to college and early adulthood. Participants will examine strategies to support executive functioning, academic success, and autonomy, while implementing safe and evidence-based pharmacologic and non-pharmacologic interventions. Special attention will be given to care transitions, prevention of stimulant misuse or diversion, and maintaining treatment continuity during this critical developmental stage.

12:05 pm - 12:50 pm ET

Industry Session^†: More information to come

12:50 pm - 1:30 pm ET

Live Panel Q&A

^†The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. These events are not part of the scientific program and do not provide CME/CE credit. By opening a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.

Program Faculty

Andrew J. Cutler, MD

Clinical Associate Professor of Psychiatry, SUNY Upstate Medical University

Chief Medical Officer, Neuroscience Education Institute, Malvern, PA

Jeffrey R. Strawn, MD

Tenured Professor of Psychiatry and Behavioral Neuroscience, Pediatrics, and Clinical and Translational Pharmacology

Director, Anxiety Disorders Research Program

Co-Director, Center for Clinical and Translational Science and Training

University of Cincinnati, Cincinnati, OH

Explore Past Saturday Morning Live Sessions

Revisit, learn from, and enjoy recorded presentations from previous Saturday Morning Live events. Access expert-led sessions that offer practical, evidence-based insights to support your clinical work.

Encore Presentations provide 24/7 access to our on-demand library, giving you the flexibility to watch, learn, and earn credits anytime.

Start Watching